Results 71 to 80 of about 104 (86)

Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in outpatients with anorexia nervosa (ANTOP study): randomised controlled trial

Lancet, The, 2014
Stephan Zipfel, Beate Wild, Hans-Christoph Friederich   +2 more
exaly  

5-HT2A promoter polymorphism in anorexia nervosa

Lancet, The, 1998
Sandro Sorbi, Benedetta Nacmias, Valdo Ricca   +2 more
exaly  

Abnormal Hypothalamic–Pituitary–Adrenal Function in Anorexia Nervosa

New England Journal of Medicine, 1986
George P Chrousos
exaly  

Association between 5-HT2A gene promoter polymorphism and anorexia nervosa

Lancet, The, 1997
David A Collier, Tao Li, Janet Treasure, Frcp, Frcpsych, Faed, Obe   +2 more
exaly  

Cortisol Secretion and Metabolism in Anorexia Nervosa

New England Journal of Medicine, 1977
H Leon Bradlow
exaly  

Day-patient treatment after short inpatient care versus continued inpatient treatment in adolescents with anorexia nervosa (ANDI): a multicentre, randomised, open-label, non-inferiority trial

Lancet, The, 2014
Beate Herpertz-Dahlmann, Karin Egberts, André Scherag   +2 more
exaly  

Functional anatomy of calorie fear in anorexia nervosa

Lancet, The, 1998
E T Bullmore, Janet Treasure, Frcp, Frcpsych, Faed, Obe   +1 more
exaly  

Behavioral Management for Anorexia Nervosa

New England Journal of Medicine, 2009
Evelyn Attia, B Timothy Walsh
exaly  

Lack of association between 5-HT2A gene promoter polymorphism and susceptibility to anorexia nervosa

Lancet, The, 1998
exaly  

Abnormalities in Plasma and Cerebrospinal-Fluid Arginine Vasopressin in Patients with Anorexia Nervosa

New England Journal of Medicine, 1983
exaly